Jim Cramer Says “Danaher’s Been Acting Much Better”

Company Overview - Danaher Corporation (NYSE:DHR) is a conglomerate focused on life sciences diagnostics, having spun off its water and product quality testing business as Veralto [1] - The company provides instruments, consumables, software, and services used in bioprocessing, life sciences research, and clinical diagnostics [2] Recent Performance - Danaher has seen a stock increase of 31% from its April low and 25% from its recent low in September [1] - The company reported a strong quarter with a small revenue beat and solid 3% organic growth, alongside a significant earnings beat [1] Future Outlook - Wall Street anticipates Danaher will achieve its best growth in years by 2026, projecting mid-single-digit revenue growth and high single-digit earnings growth [1]